Literature DB >> 12461303

Reproducibility of blood pressure response to hydrochlorothiazide.

Javier D Finkielman1, Gary L Schwartz, Arlene B Chapman, Eric Boerwinkle, Stephen T Turner.   

Abstract

Few studies have investigated the reproducibility of responses to antihypertensive therapies. The purpose of this study was to assess the reproducibility of the blood pressure response to a thiazide diuretic, a preferred initial treatment for hypertension. Twenty-two subjects who underwent monotherapy with hydrochlorothiazide as part of a study to identify predictors of blood pressure response agreed to undergo the same protocol a second time, 26.6+/-11.8 (range, 4-52) months after their first participation. The mean systolic and diastolic blood pressure responses to hydrochlorothiazide did not differ significantly between the first and second participation (systolic response, -14.2+/-16.4 mm Hg vs. -16.0+/-16.5 mm Hg; diastolic response, -7.1+/-11.8 mm Hg vs. -6.6+/-8.6 mm Hg), and these responses were significantly correlated between the two trials (systolic response, r=0.61 and p<0.01; diastolic response, r=0.64 and p<0.01). However, both the direction and magnitude of responses for individual subjects varied considerably, with the limits of agreement between the first and second participations (i.e., 2 standard deviations above and below the mean difference between responses) ranging from 27.4 mm Hg to -23.8 mm Hg for systolic blood pressure response and from 17.4 mm Hg to -18.4 mm Hg for diastolic blood pressure response. These results show that the average systolic and diastolic blood pressure responses to hydrochlorothiazide for a group of subjects are reproducible; however, the responses for individual subjects are unpredictable. Copyright 2002 Le Jacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461303      PMCID: PMC8101852          DOI: 10.1111/j.1524-6175.2002.00965.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  12 in total

1.  Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response.

Authors:  S Ragot; N Genès; L Vaur; D Herpin
Journal:  Am J Hypertens       Date:  2000-06       Impact factor: 2.689

2.  Variability of indirect methods used to determine blood pressure. Office vs mean 24-hour automated blood pressures.

Authors:  P B Bottini; A A Carr; R B Rhoades; L M Prisant
Journal:  Arch Intern Med       Date:  1992-01

3.  C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic.

Authors:  S T Turner; G L Schwartz; A B Chapman; E Boerwinkle
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

Review 4.  Antihypertensive pharmacogenetics: getting the right drug into the right patient.

Authors:  S T Turner; G L Schwartz; A B Chapman; W D Hall; E Boerwinkle
Journal:  J Hypertens       Date:  2001-01       Impact factor: 4.844

5.  Variation of blood-pressure in untreated hypertensive outpatients.

Authors:  J F Dunne
Journal:  Lancet       Date:  1969-02-22       Impact factor: 79.321

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  The variability of measurements of casual blood pressure. I. A laboratory study.

Authors:  P Armitage; G A Rose
Journal:  Clin Sci       Date:  1966-04       Impact factor: 6.124

8.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

9.  Reproducibility of the response to short-term low salt intake in essential hypertension.

Authors:  C Zoccali; F Mallamaci; F Cuzzola; D Leonardis
Journal:  J Hypertens       Date:  1996-12       Impact factor: 4.844

10.  Variation in cuff blood pressure in untreated outpatients with mild hypertension--implications for initiating antihypertensive treatment.

Authors:  R D Watson; R Lumb; M A Young; T J Stallard; P Davies; W A Littler
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

View more
  4 in total

Review 1.  Gene markers and antihypertensive therapy.

Authors:  Stephen T Turner; Gary L Schwartz
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

2.  Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.

Authors:  Stephen T Turner; Kent R Bailey; Brooke L Fridley; Arlene B Chapman; Gary L Schwartz; High Seng Chai; Hugues Sicotte; Jean-Pierre Kocher; Andréi S Rodin; Eric Boerwinkle
Journal:  Hypertension       Date:  2008-06-30       Impact factor: 10.190

3.  Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.

Authors:  Michael T Eadon; Sri H Kanuri; Arlene B Chapman
Journal:  Expert Rev Precis Med Drug Dev       Date:  2018-01-03

4.  Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.

Authors:  Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-Dehoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Journal:  J Transl Med       Date:  2012-03-13       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.